HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Hahka-Kemppinen Selected Research

M Hahka-Kemppinen Research Topics

Disease

7Melanoma (Melanoma, Malignant)
09/2001 - 01/2000
4Neoplasm Metastasis (Metastasis)
09/2001 - 06/2000
4Neoplasms (Cancer)
08/2000 - 06/2000
1Breast Neoplasms (Breast Cancer)
05/2010
1Uveal melanoma
05/2003
1Disease Progression
01/2000

Drug/Important Bio-Agent (IBA)

1Docetaxel (Taxotere)FDA Link
05/2010
1GemcitabineFDA Link
05/2010
1Vincristine (Oncovin)FDA LinkGeneric
05/2003
1Interferon alpha-2 (Roferon-A)FDA Link
05/2003
1Bleomycin (Blenoxane)FDA LinkGeneric
05/2003
1Dacarbazine (DIC)FDA LinkGeneric
05/2003
1InterferonsIBA
05/2003
1Lomustine (CCNU)FDA Link
05/2003
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
09/2001
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
09/2001
1Interleukin-2 Receptors (IL 2 Receptor)IBA
09/2001
1collagenase 1IBA
04/2001
1Peptide Hydrolases (Proteases)FDA Link
04/2001
1Matrix Metalloproteinases (MMPs)IBA
04/2001
1Proteins (Proteins, Gene)FDA Link
08/2000
1Interleukin-10 (Interleukin 10)IBA
06/2000
1Interleukin-12 (IL 12)IBA
06/2000
1InterleukinsIBA
06/2000
1Interleukin-6 (Interleukin 6)IBA
06/2000
1Integrin beta1IBA
06/2000
1S100 Calcium Binding Protein beta SubunitIBA
06/2000
1IntegrinsIBA
06/2000
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2000

Therapy/Procedure

2Drug Therapy (Chemotherapy)
05/2010 - 05/2003
1Time-to-Treatment
05/2010
1Aftercare (After-Treatment)
08/2000
1Conservative Treatment
08/2000